CLEVELAND, Ohio (WOIO) – Harrington Discovery Institute at University Hospitals is supporting the development of a new drug called Zalinfiban that helped thousands of heart attack patients avoid complications in clinical trials.
The eventual goal is to allow patients to self-administer the medication at home.
Dr. Barry Coller, the primary inventor of Zalinfiban, said the investigational anti-platelet drug is designed to reduce clot formation during heart attacks…